Stem cell therapy for knee osteoarthritis
Treatments studied
Part of Bones, joints & muscles clinical trials.
This trial tests a new stem cell treatment (UC-MSCs) for knee osteoarthritis. It aims to see if this treatment is safe and can help reduce pain and improve knee function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 70 years old.
- You have been diagnosed with knee osteoarthritis for at least 4 weeks.
- Your knee pain score is between 5 and 7 on a 0–10 scale (moderate pain).
- You have not had any knee surgery, infection, or injection in the last 3–6 months.
- You are willing to stop taking certain pain relievers before the study starts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether special stem cells (called UC-MSCs, derived from umbilical cord tissue) can reduce pain and improve function in people with moderate knee osteoarthritis. Researchers will inject these cells into your knee to see if they help repair damaged cartilage and reduce inflammation.
This study tests a new stem cell treatment for knee osteoarthritis. It aims to see if injecting these cells into the knee can reduce pain and improve function compared to other treatments.
This trial tests a new treatment using donor stem cells injected into the knee for people with moderate knee osteoarthritis. It aims to see if these cells can reduce pain and improve function.
This early-phase study tests an injection of donor stem cells placed into the knee joint to help reduce symptoms of knee osteoarthritis. You may be eligible if you have long-lasting knee pain from mild-to-moderate arthritis and meet safety and imaging requirements.
This study tests a stem cell injection for knee osteoarthritis in patients who previously received a placebo. It aims to see if the treatment is safe and effective over a longer period.
This trial tests a new stem cell treatment (NCR100) for knee osteoarthritis. It aims to see if the injection can reduce pain and improve knee function in people with moderate knee OA.
Hear when a new Knee Osteoarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.